Depatuxizumab

DB12826InvestigationalProtein Based Therapies

Depatuxizumab has been used in trials studying the treatment and diagnostic of Adenocarcinoma and Advanced Solid Tumors.

Mechanism: Pharmacologically active on Epidermal growth factor receptor
Curator reviewed
Code names: ABT-806

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

382Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Depatuxizumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.